Daily Filing Digest — 13 Sep 2026

A genuinely quiet Sunday — just 10 filings, mostly procedural voting results and scrutiniser reports. The one real story: a small heat-exchanger manufacturer landed a $23.66 million export order from one of Africa's largest refineries.

The one to read first

Patels Airtemp (India) won a USD 23.66 million (~₹226 crore) order from Dangote Petroleum Refinery and Petrochemicals in Nigeria, for air-cooled heat exchangers to be delivered over 12 months on a fixed-price basis. It's a genuinely large order relative to the company's size, and a named, verifiable customer rather than the "single order, customer not disclosed" framing the raw filing summary carried.

Also filed

Lenskart Solutions increased its stake in associate company Dimension NXG (branded Ajna, an XR/smart-eyewear firm) to 9.01% with a fresh ₹8 crore (₹79.97 million) investment — its third such stake purchase this year, following 0.68% in February and 1.69% in July, for a cumulative 4.17% added and ₹18.5 crore spent in 2026. The filing frames it as deepening Lenskart's bet on AR/MR and smart-wearable technology; as a related-party transaction (Ajna is a Lenskart associate), it was structured at arm's length.

Gland Pharma is consolidating its US operations — acquiring 100% of step-down subsidiary Gland Pharma USA directly from its wholly owned Singapore holding entity, Gland Pharma International Pte. Ltd, an internal restructuring rather than a new acquisition. DPSC Limited disclosed the voting outcome of the 7th Committee of Creditors meeting in India Power Corporation's insolvency process, without detailing the vote count or resolution-plan terms. BRPL re-appointed Kaushalkumar S. Gupta as Chairman and Managing Director.

A handful of routine items closed out the day: scrutiniser's reports and voting results from Hybrid Financial Services, SIDH Finserve and other AGM/EGM filings, none disclosing resolution-level outcomes in the summary text; Horizon Industrial Parks filed its Q1 FY27 earnings-call transcript from the prior week; and Tempsens Instruments and Prime Fresh Limited carried standard scheduling and regulatory-approval notices.

Educational research, not investment advice. Figures above are drawn from primary filings and independently cross-checked against secondary financial-news coverage in every case where a specific number is cited. No buy/sell recommendations, no price targets. Moat & Margin is not a SEBI-registered Research Analyst or Investment Adviser.